MYO · Myomo, Inc.
Market Cap
$63.77M
Shares
39.61M
Volume · Oct 5
272.93K
Avg daily vol (3M)
498.88K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.63
Open$1.64
Day$1.61–1.70
52W close$0.64–1.86
Avg vol 30d430K
Short int1.2M · 3.0% float · 3.6d
Short vol66%
Last earningsAug 5, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 4, 2026
Est · unconfirmed
· in 4 wks
filed Aug 5, 2026
call held May 7, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+77.8%
Trailing year
Short interest
3.0%
Latest settlement · 3.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+56%
above
Price vs 50-day avg
+15%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
81%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+16%
trailing
6-month return
+123%
trailing
YTD return
+79%
this year
Relative strength
+111%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-4% holders QoQ · +21 funds added
Insider flow
Distributing
Net -$71.2K over 90 days · 100% sells
Short interest
Rising
3.02% of float · ▲ +0.5% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
79 holders — mid 3-yr range
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
+57%
Y/Y
Gross margin
1100%
contracting
EPS growth
−131%
Y/Y
Free cash flow
$-16.3M
Balance sheet
$2.9M
net cash
Quant / Vol
risk profile
Volatility
96%
annualized · 1-yr
Max drawdown
−46%
past year
ATR
7.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 5, 2026
third quarter 2026
Third quarter 2026 revenue
Initiated
$11.5M – $12M
prior qtr $11.7M
midpoint +0.4% QoQ
full year
Full year revenue
$45M – $47M
prior FY $40.93M
midpoint +12.4% Y/Y
Guided vs delivered
· last 5 settled
Third quarter revenue
third quarter
guided $8M – $8.5M
$9.21M
Beat +11.6%
Full year revenue
full year
guided $28M – $30M
$32.55M
Beat +12.2%
Revenue
first quarter 2024
guided $4.1M – $4.3M
$3.75M
Miss −10.6%
Total revenue
first quarter of 2022
guided $8.8M
$3.87M
Miss −56.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+56%
Bullish
Price vs 50-day avg
+15%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
81%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow
Distributing
-4% holders QoQ · +21 funds added
Insider flow
Distributing
Net -$71.2K over 90 days · 100% sells
Short interest
Rising
3.02% of float · ▲ +0.5% MoM · 3.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
79 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $2 · 81%
Range high $2
vs 200-day avg +56%
vs 50-day avg +15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$3,095,496 | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA loss non-GAAP | $0.8M | the second quarter | — |
| Average selling price | $55,500 | the second quarter | — |
| MyoPro units | 211 | the second quarter | — |
| Orders | 255 | the second quarter | — |
| Pipeline additions | 739 | the second quarter | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MYO
this stock
Myomo, Inc.
|
$63.77M | +79.1% | +56.8% | — | 3.0% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MYO | +1.2% | +16.4% | +123.3% | +4.5% | +79.1% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +1.5% | +16.9% | +111.1% | +3.6% | +66.3% |